{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:41:24Z","timestamp":1793821284079,"version":"4.6.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03454-9","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:38:30Z","timestamp":1791545910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Curcumin in ovarian cancer: mechanistic insights and translational potential"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8860-7699","authenticated-orcid":false,"given":"Mojtaba","family":"Esmaeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8298-4975","authenticated-orcid":false,"given":"Maryam","family":"Dehghanpour Dehabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"issue":"1","key":"3454_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. Ca. 2025;75(1):10.","journal-title":"Ca"},{"key":"3454_CR2","doi-asserted-by":"crossref","unstructured":"Kanno M, Yunokawa M, Fusegi A, Miyazaki N, Nishino S, Tanigawa T et al. The impact of cytoreductive surgery on outcomes in high tumor burden ovarian cancer after induction of PARP inhibitors. J Gynecologic Oncol. 2024;36.","DOI":"10.3802\/jgo.2025.36.e91"},{"issue":"1","key":"3454_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s12672-026-04702-0","volume":"17","author":"W Chen","year":"2026","unstructured":"Chen W, Shi W, Chan HL, Wang Y, Di W. Cell-intrinsic and tumor microenvironmental determinants of platinum resistance in epithelial ovarian cancer. Discover Oncol. 2026;17(1):523.","journal-title":"Discover Oncol"},{"key":"3454_CR4","doi-asserted-by":"crossref","unstructured":"McMullen M, Madariaga A, Lheureux S, editors. New approaches for targeting platinum-resistant ovarian cancer. Seminars in cancer biology. Elsevier; 2021.","DOI":"10.1016\/j.semcancer.2020.08.013"},{"issue":"6","key":"3454_CR5","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/cancers11060838","volume":"11","author":"N Loret","year":"2019","unstructured":"Loret N, Denys H, Tummers P, Berx G. The role of epithelial-to-mesenchymal plasticity in ovarian cancer progression and therapy resistance. Cancers. 2019;11(6):838.","journal-title":"Cancers"},{"key":"3454_CR6","doi-asserted-by":"crossref","unstructured":"Wu Y, Sun R, Liang J, Zengin G, Li M-Y. Food and medicine homology substances in cancer management. Food Science and Human Wellness; 2026.","DOI":"10.26599\/FSHW.2026.9251048"},{"issue":"2","key":"3454_CR7","first-page":"200","volume":"4","author":"M-Y Li","year":"2025","unstructured":"Li M-Y, Gu A, Li J, Tang N, Matin M, Yang Y, et al. Exploring food and medicine homology: potential implications for cancer treatment innovations. Acta Materia Med. 2025;4(2):200\u20136.","journal-title":"Acta Materia Med"},{"issue":"4","key":"3454_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/med4.70044","volume":"3","author":"Y Wu","year":"2025","unstructured":"Wu Y, Sun R, Ren S, Zengin G, Li M. Neuronal reshaping of the tumor microenvironment in tumorigenesis and metastasis: bench to clinic. Med Adv. 2025;3(4):364\u201371.","journal-title":"Med Adv"},{"issue":"8","key":"3454_CR9","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1080\/01635581.2022.2049321","volume":"74","author":"M Mohamadian","year":"2022","unstructured":"Mohamadian M, Bahrami A, Moradi Binabaj M, Asgharzadeh F, Ferns GA. Molecular targets of curcumin and its therapeutic potential for ovarian cancer. Nutr Cancer. 2022;74(8):2713\u201330.","journal-title":"Nutr Cancer"},{"issue":"1","key":"3454_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/pharmaceutics17010114","volume":"17","author":"H Wahnou","year":"2025","unstructured":"Wahnou H, El Kebbaj R, Liagre B, Sol V, Limami Y, Duval RE. Curcumin-Based Nanoparticles: Advancements and Challenges in Tumor Therapy. Pharmaceutics. 2025;17(1):114.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3454_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13048-023-01120-6","volume":"16","author":"X Liu","year":"2023","unstructured":"Liu X, Qi M, Li X, Wang J, Wang M. Curcumin: a natural organic component that plays a multi-faceted role in ovarian cancer. J ovarian Res. 2023;16(1):47.","journal-title":"J ovarian Res"},{"key":"3454_CR12","doi-asserted-by":"publisher","first-page":"1014933","DOI":"10.3389\/fphar.2022.1014933","volume":"13","author":"Y Liu","year":"2023","unstructured":"Liu Y, Shen Z, Zhu T, Lu W, Fu Y. Curcumin enhances the anti-cancer efficacy of paclitaxel in ovarian cancer by regulating the miR-9-5p\/BRCA1 axis. Front Pharmacol. 2023;13:1014933.","journal-title":"Front Pharmacol"},{"issue":"5","key":"3454_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-025-02682-9","volume":"42","author":"X Li","year":"2025","unstructured":"Li X, Su L, Qian C, Qiu W, Tao L, Guo Z, et al. Curcumin suppresses malignant behaviors of ovarian cancer through regulation of tumor-associated macrophages. Med Oncol. 2025;42(5):1\u201312.","journal-title":"Med Oncol"},{"key":"3454_CR14","doi-asserted-by":"publisher","first-page":"1509045","DOI":"10.3389\/fphar.2025.1509045","volume":"16","author":"M Hao","year":"2025","unstructured":"Hao M, Zhang C, Wang T, Hu H. Pharmacological effects, formulations, and clinical research progress of curcumin. Front Pharmacol. 2025;16:1509045.","journal-title":"Front Pharmacol"},{"issue":"16","key":"3454_CR15","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.3390\/molecules26164998","volume":"26","author":"H Chopra","year":"2021","unstructured":"Chopra H, Dey PS, Das D, Bhattacharya T, Shah M, Mubin S, et al. Curcumin nanoparticles as promising therapeutic agents for drug targets. Molecules. 2021;26(16):4998.","journal-title":"Molecules"},{"key":"3454_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, De Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:1\u20139.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"3454_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s11671-020-03302-3","volume":"15","author":"X Guo","year":"2020","unstructured":"Guo X, Mei J, Jing Y, Wang S. Curcumin-loaded nanoparticles with low-intensity focused ultrasound-induced phase transformation as tumor-targeted and pH-sensitive theranostic nanoplatform of ovarian cancer. Nanoscale Res Lett. 2020;15(1):73.","journal-title":"Nanoscale Res Lett"},{"issue":"11","key":"3454_CR18","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.3390\/molecules25112621","volume":"25","author":"X Guo","year":"2020","unstructured":"Guo X, Fang Z, Zhang M, Yang D, Wang S, Liu K. A co-delivery system of curcumin and p53 for enhancing the sensitivity of drug-resistant ovarian cancer cells to cisplatin. Molecules. 2020;25(11):2621.","journal-title":"Molecules"},{"issue":"19","key":"3454_CR19","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.3390\/molecules25194471","volume":"25","author":"LG Freidus","year":"2020","unstructured":"Freidus LG, Kumar P, Marimuthu T, Pradeep P, Pillay V, Choonara YE. Synthesis and properties of CurNQ for the theranostic application in ovarian cancer intervention. Molecules. 2020;25(19):4471.","journal-title":"Molecules"},{"issue":"1","key":"3454_CR20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12905-020-01122-2","volume":"20","author":"MJ Kim","year":"2020","unstructured":"Kim MJ, Park K-S, Kim K-T, Gil EY. The inhibitory effect of curcumin via fascin suppression through JAK\/STAT3 pathway on metastasis and recurrence of ovary cancer cells. BMC Womens Health. 2020;20(1):256.","journal-title":"BMC Womens Health"},{"issue":"1","key":"3454_CR21","first-page":"128","volume":"12","author":"AJ Barinda","year":"2020","unstructured":"Barinda AJ, Arozal W, Sandhiutami NMD, Louisa M, Arfian N, Sandora N, et al. Curcumin prevents epithelial-to mesenchymal transition-mediated ovarian cancer progression through nrf2\/etbr\/et-1 axis and preserves mitochondria biogenesis in kidney after cisplatin administration. Adv Pharm Bull. 2020;12(1):128.","journal-title":"Adv Pharm Bull"},{"key":"3454_CR22","doi-asserted-by":"crossref","unstructured":"Hu Y, Ran M, Wang B, Lin Y, Cheng Y, Zheng S. Co-delivery of docetaxel and curcumin via nanomicelles for enhancing anti-ovarian cancer treatment. Int J Nanomed. 2020:9703\u201315.","DOI":"10.2147\/IJN.S274083"},{"issue":"1","key":"3454_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13048-021-00916-8","volume":"14","author":"S Sun","year":"2021","unstructured":"Sun S, Fang H. Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3\/miR-320a\/SMG1 axis. J Ovarian Res. 2021;14(1):158.","journal-title":"J Ovarian Res"},{"issue":"1","key":"3454_CR24","doi-asserted-by":"publisher","first-page":"23025","DOI":"10.1038\/s41598-021-02454-1","volume":"11","author":"F Ravindran","year":"2021","unstructured":"Ravindran F, Koroth J, Manjunath M, Narayan S, Choudhary B. Curcumin derivative ST09 modulates the miR-199a-5p\/DDR1 axis and regulates proliferation and migration in ovarian cancer cells. Sci Rep. 2021;11(1):23025.","journal-title":"Sci Rep"},{"key":"3454_CR25","doi-asserted-by":"publisher","first-page":"603235","DOI":"10.3389\/fphar.2020.603235","volume":"11","author":"NMD Sandhiutami","year":"2021","unstructured":"Sandhiutami NMD, Arozal W, Louisa M, Rahmat D, Wuyung PE. Curcumin nanoparticle enhances the anticancer effect of cisplatin by inhibiting PI3K\/AKT and JAK\/STAT3 pathway in rat ovarian carcinoma induced by DMBA. Front Pharmacol. 2021;11:603235.","journal-title":"Front Pharmacol"},{"issue":"23","key":"3454_CR26","doi-asserted-by":"publisher","first-page":"7220","DOI":"10.3390\/jcm11237220","volume":"11","author":"N Zheng","year":"2022","unstructured":"Zheng N, Liu S, Zeng H, Zhao H, Jin L. Molecular mechanism of Curcumin Derivative on YAP pathway against Ovarian Cancer. J Clin Med. 2022;11(23):7220.","journal-title":"J Clin Med"},{"issue":"14","key":"3454_CR27","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.3390\/molecules27144565","volume":"27","author":"J Leskovsk\u00e1","year":"2022","unstructured":"Leskovsk\u00e1 J, Mikl\u00e1\u0161ov\u00e1 N, Kubelac PM, Achima\u015f-Cadariu P, Valentov\u00e1 J, Markuliak M, et al. Antiproliferative Ruthenium Complexes Containing Curcuminoid Ligands Tested In Vitro on Human Ovarian Tumor Cell Line A2780, towards Their Capability to Modulate the NF-\u03ba BTranscription Factor, FGF-2 Growth Factor, and MMP-9 Pathway. Molecules. 2022;27(14):4565.","journal-title":"Molecules"},{"issue":"1","key":"3454_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40659-023-00412-x","volume":"56","author":"E Seyed Hosseini","year":"2023","unstructured":"Seyed Hosseini E, Alizadeh Zarei M, Tarrahimofrad H, Zamani J, Haddad Kashani H, Ahmad E, et al. Synergistic effects of dendrosomal nanocurcumin and oxaliplatin on oncogenic properties of ovarian cancer cell lines by down-expression of MMPs. Biol Res. 2023;56(1):3.","journal-title":"Biol Res"},{"issue":"1","key":"3454_CR29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/13880209.2023.2166965","volume":"61","author":"M Louisa","year":"2023","unstructured":"Louisa M, Wanafri E, Arozal W, Sandhiutami NMD, Basalamah AM. Nanocurcumin preserves kidney function and haematology parameters in DMBA-induced ovarian cancer treated with cisplatin via its antioxidative and anti-inflammatory effect in rats. Pharm Biol. 2023;61(1):298\u2013305.","journal-title":"Pharm Biol"},{"issue":"10","key":"3454_CR30","doi-asserted-by":"publisher","first-page":"9021","DOI":"10.3390\/ijms24109021","volume":"24","author":"N Al-Moghrabi","year":"2023","unstructured":"Al-Moghrabi N, Al-Showimi M, Al-Yousef N, AlOtai L. MicroRNA-155-5p, reduced by curcumin-re-expressed hypermethylated BRCA1, is a molecular biomarker for cancer risk in BRCA1-methylation Carriers. Int J Mol Sci. 2023;24(10):9021.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3454_CR31","first-page":"5156320","volume":"2023","author":"M Nourbakhsh","year":"2023","unstructured":"Nourbakhsh M, Noori S, Aminzade Z, Bayanati M, Alemi M, Zarghi A. Attenuation of Inflammatory Responses in Breast and Ovarian Cancer Cells by a Novel Chalcone Derivative and Its Increased Potency by Curcumin. Mediat Inflamm. 2023;2023(1):5156320.","journal-title":"Mediat Inflamm"},{"issue":"1","key":"3454_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/ijms26010041","volume":"26","author":"J We\u017cgowiec","year":"2024","unstructured":"We\u017cgowiec J, \u0141api\u0144ska Z, Lamch \u0141, Szewczyk A, Saczko J, Kulbacka J, et al. Cytotoxic Activity of Curcumin-and Resveratrol-Loaded Core\u2013Shell Systems in Resistant and Sensitive Human Ovarian Cancer Cells. Int J Mol Sci. 2024;26(1):41.","journal-title":"Int J Mol Sci"},{"key":"3454_CR33","doi-asserted-by":"crossref","unstructured":"Gou Q, Liu L, Wang C, Wu Q, Sun L, Yang X, et al. Polymer nanoassemblies entering curcumin excess of multidrug resistance in ovarian cancer (vol 126, pg, 26, 2015). COLLOIDS AND SURFACES B-BIOINTERFACES; 2024. p. 234.","DOI":"10.1016\/j.colsurfb.2023.113679"},{"issue":"2","key":"3454_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/ijms26020799","volume":"26","author":"AA Hasan","year":"2025","unstructured":"Hasan AA, Kalinina E, Zhdanov D, Volodina Y, Tatarskiy V. Re-Sensitization of Resistant Ovarian Cancer SKOV3\/CDDP Cells to Cisplatin by Curcumin Pre-Treatment. Int J Mol Sci. 2025;26(2):799.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3454_CR35","doi-asserted-by":"publisher","first-page":"e0319846","DOI":"10.1371\/journal.pone.0319846","volume":"20","author":"Q Bao","year":"2025","unstructured":"Bao Q, Wang Z, Yang T, Su X, Chen Y, Liu L, et al. Curcumin induces mitochondrial dysfunction-associated oxidative DNA damage in ovarian cancer cells. PLoS ONE. 2025;20(3):e0319846.","journal-title":"PLoS ONE"},{"issue":"9","key":"3454_CR36","doi-asserted-by":"publisher","first-page":"e72162","DOI":"10.1371\/journal.pone.0072162","volume":"8","author":"MS Anglesio","year":"2013","unstructured":"Anglesio MS, Wiegand KC, Melnyk N, Chow C, Salamanca C, Prentice LM, et al. Type-specific cell line models for type-specific ovarian cancer research. PLoS ONE. 2013;8(9):e72162.","journal-title":"PLoS ONE"},{"issue":"6","key":"3454_CR37","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s00404-019-05058-3","volume":"299","author":"L-d Liu","year":"2019","unstructured":"Liu L-d, Pang Y-x, Zhao X-r, Li R, Jin C-j, Xue J, et al. Curcumin induces apoptotic cell death and protective autophagy by inhibiting AKT\/mTOR\/p70S6K pathway in human ovarian cancer cells. Arch Gynecol Obstet. 2019;299(6):1627\u201339.","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"3454_CR38","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3390\/ph16070943","volume":"16","author":"F Silvestre","year":"2023","unstructured":"Silvestre F, Santos C, Silva V, Ombredane A, Pinheiro W, Andrade L, et al. Pharmacokinetics of curcumin delivered by nanoparticles and the relationship with antitumor efficacy: a systematic review. Pharmaceuticals. 2023;16(7):943.","journal-title":"Pharmaceuticals"},{"key":"3454_CR39","doi-asserted-by":"crossref","unstructured":"Kroon MA, van Laarhoven HW, Swart EL, van Tellingen O, Kemper EM. A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability. Iscience. 2025;28(6).","DOI":"10.1016\/j.isci.2025.112575"},{"issue":"2895","key":"3454_CR40","first-page":"e2900","volume":"21","author":"C Hsieh","year":"2001","unstructured":"Hsieh C. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21(2895):e2900.","journal-title":"Anticancer Res"},{"issue":"6","key":"3454_CR41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.joim.2018.07.001","volume":"16","author":"R Jamwal","year":"2018","unstructured":"Jamwal R. Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers. J Integr Med. 2018;16(6):367\u201374.","journal-title":"J Integr Med"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03454-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03454-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03454-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:38:33Z","timestamp":1791545913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03454-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3454"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03454-9","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"20 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have carefully addressed ethical considerations, including monitoring for text plagiarism, duplicate publications, research misconduct, data fabrication, and falsification.","order":4,"name":"Ethics","label":"Ethical considerations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"333"}}